Read + Share
Amedeo Smart
Independent Medical Education
Christopher MR, Nawas MT, Reagan JL. Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia. Bone Marrow Transplant 2024 Nov 13. doi: 10.1038/s41409-024-02465.PMID: 39537780
Email
LinkedIn
Privacy Policy